|
(PQ5) Exploring the Biological Distinctions between HIV-related and Endemic Pediatric Kaposi Sarcoma in a Kaposi Sarcoma-Associated Herpesvirus-Endemic Region of Africa
|
5R21CA217137-02
|
$196,947
|
$196,947
|
EL-MALLAWANY, NADER
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-12S1
|
$118,875
|
$1,189
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-12S2
|
$249,997
|
$2,500
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-12S3
|
$125,004
|
$1,250
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-12
|
$3,203,119
|
$32,031
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Unmasking the roles of KSHV glycoproteins in virus entry and vaccine development
|
5K01CA184388-05
|
$98,360
|
$98,360
|
OGEMBO, JAVIER
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Genetic and Biochemical Studies of KSHV LANA
|
5R01CA082036-19
|
$228,408
|
$228,408
|
KAYE, KENNETH
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Early Stage Diagnosis of Kaposis Sarcoma in Limited Resource Settings using KS-Detect
|
4UH3CA202723-03
|
$993,475
|
$993,475
|
ERICKSON, DAVID
|
CORNELL UNIVERSITY
|
|
Viral Oncology Training Grant
|
5T32CA009111-40
|
$391,340
|
$39,134
|
CULLEN, BRYAN
|
DUKE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA015704-43S1
|
$78,024
|
$1,560
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
3P30CA015704-43S2
|
$199,999
|
$4,000
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
3P30CA015704-43S3
|
$246,630
|
$4,933
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
3P30CA015704-43S4
|
$225,000
|
$4,500
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
3P30CA015704-43S5
|
$33,324
|
$666
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
5P30CA015704-43
|
$9,559,285
|
$191,186
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Biologic Determinants of the Natural History of AIDS-Defining Cancers in Uganda
|
5U54CA190146-05
|
$687,761
|
$337,003
|
PHIPPS, WARREN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
(PQ5) Effect of HIV infection on viral and host gene expression and antitumor immunity in Kaposi Sarcoma in Africa
|
5R01CA217138-02
|
$723,817
|
$723,817
|
WARREN, EDUS
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Mechanism and Function of Mitophagy Regulation by HHV-8 Viral Interferon Regulatory Factor-1
|
5R01CA214131-02
|
$374,578
|
$374,578
|
CHOI, YOUNG BONG
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-55S1
|
$59,984
|
$600
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-55S2
|
$199,060
|
$1,991
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
5P30CA006973-55
|
$7,069,034
|
$70,690
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Studies of HHV-8 vIL-6 Function
|
5R01CA076445-17
|
$384,750
|
$192,375
|
NICHOLAS, JOHN
|
JOHNS HOPKINS UNIVERSITY
|
|
TAS::75 0849::TAS ADMINISTRATIVE MODIFICATION
|
261200800001E
|
$313,286,406
|
$6,716
|
DMITROVSKY, ETHAN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
Periodontal bacteria enhance oral KSHV pathogenesis and Kaposi?s Sarcoma development in HIV+ patients
|
1R01CA228166-01
|
$370,000
|
$370,000
|
QIN, ZHIQIANG
|
LSU HEALTH SCIENCES CENTER
|
|
CD206 Targeted Therapy for Kaposi Sarcoma and Tumor Associated Macrophages
|
5R44CA206788-03
|
$601,993
|
$601,993
|
COPE, FREDERICK
|
NAVIDEA BIOPHARMACEUTICALS, INC.
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,537,925
|
$30,758
|
Barr, Frederic
|
CCR (NCI)
|
|
Medical Oncology Fellowship Program
|
ZIE BC 010843
|
$3,561,926
|
$178,096
|
Bilusic, Marijo
|
CCR (NCI)
|
|
Design and Synthesis of HIV Integrase as Potential Anti-AIDS Drugs
|
ZIA BC 007363
|
$256,149
|
$128,075
|
Burke, Terrence
|
CCR (NCI)
|
|
HIV and Cancer
|
ZIA CP010150 10071
|
$63,128
|
$18,938
|
Engels, Eric
|
DCEG (NCI)
|
|
Cancer Risk in Solid Organ Transplant Recipients
|
ZIA CP010150 10362
|
$146,079
|
$14,608
|
Engels, Eric
|
DCEG (NCI)
|
|
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells
|
ZIA BC 005598
|
$584,807
|
$58,481
|
Gottesman, Michael
|
CCR (NCI)
|
|
Studies on drug resistance in HIV-related Kaposi's sarcoma
|
ZIA BC 011730
|
$73,101
|
$36,550
|
Gottesman, Michael
|
CCR (NCI)
|
|
Medical Oncology HIV-AIDS Clinical Research
|
ZID BC 011683
|
$226,739
|
$68,022
|
Gulley, James
|
CCR (NCI)
|
|
Structural studies with regulatory RNAs
|
ZIA BC 011824
|
$273,106
|
$136,553
|
Le Grice, Stuart
|
CCR (NCI)
|
|
KSHV/HHV8 in sickle cell and other Ugandan populations
|
ZIA CP010176 10076
|
$22,786
|
$18,229
|
Mbulaiteye, Sam
|
DCEG (NCI)
|
|
KS gene expression & clonality
|
ZIA CP010176 10082
|
$22,786
|
$22,786
|
Mbulaiteye, Sam
|
DCEG (NCI)
|
|
Classical KS case-control studies
|
ZIA CP010214 10077
|
$113,107
|
$113,107
|
Mbulaiteye, Sam
|
DCEG (NCI)
|
|
CCR Vaccine Branch FACS Core
|
ZIC BC 010936
|
$351,148
|
$70,230
|
McKinnon, Katherine
|
CCR (NCI)
|
|
HIV Integrase Modeling and Computer-Aided Inhibitor and Microbicide Development
|
ZIA BC 010524
|
$201,656
|
$100,828
|
Nicklaus, Marc
|
CCR (NCI)
|
|
KSHV serological and molecular epidemiology studies
|
ZIA CP005782 10075
|
$39,629
|
$39,629
|
O'Brien, Thomas
|
DCEG (NCI)
|
|
Human Immunodeficiency Virus Epidemiology Research Study (HERS)
|
ZIA CP005782 10426
|
$39,629
|
$15,852
|
O'Brien, Thomas
|
DCEG (NCI)
|
|
Immunotherapeutic Approaches for AIDS
|
ZIA BC 010749
|
$1,077,910
|
$538,955
|
Pavlakis, George
|
CCR (NCI)
|
|
Molecular Diagnostics Core Laboratory
|
ZIC BC 011079
|
$1,573,322
|
$31,466
|
Raffeld, Mark
|
CCR (NCI)
|
|
Development of a Vaccine for HIV-AIDS: Humoral Immunity
|
ZIA BC 011058
|
$1,180,923
|
$354,277
|
Robert-Guroff, Marjorie
|
CCR (NCI)
|
|
Development of a Vaccine for HIV-AIDS: Cellular Immunity
|
ZIA BC 011062
|
$708,554
|
$233,823
|
Robert-Guroff, Marjorie
|
CCR (NCI)
|
|
Development of a Vaccine for HIV-AIDS: Translation to the Clinic
|
ZIA BC 011063
|
$472,369
|
$155,882
|
Robert-Guroff, Marjorie
|
CCR (NCI)
|
|
Biostatistics and Data Management Section
|
ZID SC 007202
|
$570,325
|
$28,516
|
Steinberg, Seth
|
CCR (NCI)
|
|
A Role for KSHV in the Pathogenesis of Malignancies
|
ZIA SC 010356
|
$305,473
|
$122,189
|
Tosato, Giovanna
|
CCR (NCI)
|
|
Study of Tumor Pathogenesis and Development of Therapies for AIDS Malignancies
|
ZIA BC 010885
|
$659,879
|
$197,964
|
Yarchoan, Robert
|
CCR (NCI)
|
|
Clinical Trials of Patients with AIDS-Related Malignancies
|
ZIA BC 010888
|
$940,327
|
$282,098
|
Yarchoan, Robert
|
CCR (NCI)
|
Total relevant funding to Kaposi Sarcoma for this search: $29,866,256
|